Describes the use of cyclooxygenase-two inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. Molecular structures of celecoxib and rofecoxib; Chemopreventive agents; Sensitization of cancer cells to apoptotic signals.
Publication
JNCI: Journal of the National Cancer Institute, 2002, Vol 94, Issue 23, p1745